1. Articles from Bioptigen

    1-15 of 15
    1. Leica Microsystems to Acquire OCT Company Bioptigen

      Leica Microsystems to Acquire OCT Company Bioptigen

      Integration of Optical Coherence Tomography (OCT) Opens up New Avenues for Ophthalmology and Life Science Research Leica Microsystems, a global leader in microscopy and imaging systems, has signed a definitive agreement to acquire Bioptigen, Inc. to strengthen its position in the ophthalmology market. Bioptigen is a technology leader in the field of optical coherence tomography (OCT). The integration of OCT imaging into Leica Microsystems’ surgical microscopes will assist ophthalmologists during eye surgery. Bioptigen develops and manufactures innovative OCT systems and software and is globally successful with products for clinical as well as translational research applications. Using low-power, near-infrared light, Bioptigen ...

      Read Full Article
      Mentions: Leica
    2. Bioptigen Receives New US Patent for Intrasurgical OCT System

      Bioptigen Receives New US Patent for Intrasurgical OCT System

      Foundational patent for intrasurgical OCT marks the company's focus on emerging market for ophthalmic surgical imaging MORRISVILLE, NC August 5, 2014 Bioptigen Inc. announces today that it has received a new US Patent presenting innovative concepts integrating Optical Coherence Tomography (OCT) Systems to Surgical Microscopes. The patent, US 8,777,412 Surgical Microscopes Using Optical Coherence Tomography and Related Methods, by Buckland E.L., et. al. includes claims for independent OCT focus and zoom control for optimizing images from the cornea to the retina, and puts forward key elements of Bioptigen's approach for incorporating OCT into new and ...

      Read Full Article
      Mentions: Leica
    3. Bioptigen Unveils the Envisu IntraSurgical OCT System for Real-time Imaging During Ophthalmic Surgery

      Bioptigen Unveils the Envisu IntraSurgical OCT System for Real-time Imaging During Ophthalmic Surgery

      Bioptigen Inc. today unveiled the Envisu IntraSurgical OCT for real-time imaging during ophthalmic surgical procedures. Key attributes of the Envisu IntraSurgical OCT include a wide, flat scan for accurate structural reproduction, and focal controls that operate independently of the microscope. These innovations will provide the surgeon with maximal versatility to assess surface and sub-surface tissue structures during surgical manipulations. Bioptigen’s Envisu IntraSurgical OCT is modularly designed for compatibility with new and existing operating microscopes to extend the power of OCT to surgical ophthalmology. "This advance brings surgeons one step closer to realizing the full value of intraoperative OCT", said ...

      Read Full Article
    4. Bioptigen Introduces Image-Guided SDOCT Technology to Advance Preclinical Eye Research

      Bioptigen Introduces Image-Guided SDOCT Technology to Advance Preclinical Eye Research

      Bioptigen announced today the availability of EnFace TM color fundus technology delivering image-guided SDOCT into a single, compact, handheld scan head. The new color fundus system provides multiple, integrated modalities into each of Bioptigen’s Envisu TM preclinical SDOCT systems, producing brilliant, color fundus images captured simultaneously with OCT images. The new color image-guided OCT also complements Bioptigen’s volumetric OCT image visualization, and dynamic 3D tissue flattening capabilities to create a powerful, comprehensive suite of tools designed to meet the exacting needs of the ophthalmic research community. Bioptigen's new Envisu SDOCT scan head featuring integrated color fundus camera ...

      Read Full Article
      Mentions: Leica
    5. Bioptigen Introduces Dynamic 3D Tissue Flattening Software for Envisu SD-OCT Systems (See Video)

      Bioptigen Introduces Dynamic 3D Tissue Flattening Software for Envisu SD-OCT Systems  (See Video)

      Bioptigen Inc. announced today the introduction of Envisu Apps, modular image processing software for improved analysis and visualization of high resolution volumetric OCT images. The first app, named Dynamic 3D Tissue Flattening uses fully automated retinal layer segmentations for enhanced en face views. These retinal layer segmentations allow users to eliminate motion artifacts (such as respiration, cardiac, etc.) which often occur during in vivo image acquisition, thus en face views appear perfectly flat across the entire image. “Single pixel slices are possible across the whole 3D image, allowing uniform sampling of data along a warped contour that ‘cuts’ through the ...

      Read Full Article
      Mentions: Leica
    6. Bioptigen now shipping Envisu XHR Extreme Resolution OCT Imaging systems

      Bioptigen now shipping Envisu XHR Extreme Resolution OCT Imaging systems

      Bioptigen (www.bioptigen.com) announces today it has begun shipping the Envisu TM S4100 XHR spectral domain optical coherence tomography research system capable of producing volumetric images with unmatched 1 um axial resolution. The system is the only OCT system in the world capable of acquiring images with 1.5 um x 1.5 um x 1 um voxel size. Additionally, this resolution is delivered in full volumes up to 1000 x 1000 x 1000 pixels, designed so that researchers do not miss the earliest signatures of pathology. Bioptigen achieves this capability with a focus on precision optical design, proprietary ...

      Read Full Article
      Mentions: NKT Photonics Leica
    7. Bioptigen introduces operating microscope mount for FDA-cleared Envisu ophthalmic imaging system.

      Bioptigen introduces operating microscope mount for FDA-cleared Envisu ophthalmic imaging system.

      Bioptigen Press Release - New microscope attachment increases options for OCT imaging of supine anesthetized patients. Bioptigen Inc. introduced today the ES100, a mounting attachment that enables users of the handheld Bioptigen Envisu TM C2300 spectral domain ophthalmic imaging system to benefit from the mechanical controls of popular operating microscopes. The ES100 mounts to the undercarriage of Zeiss and Leica microscope heads, providing a secure and stable mount when hand held imaging is not desired. With the ES100, clinicians can efficiently target areas of interest, and reduce motion artifacts when maximum stability is the objective. The attachment is at right-angle to ...

      Read Full Article
    8. Bioptigen introduces 1 µm resolution SD-OCT imaging system in collaboration with NKT Photonics supercontinuum white light laser source at ARVO conference in Seattle

      Bioptigen introduces 1 µm resolution SD-OCT imaging system in collaboration with NKT Photonics supercontinuum white light laser source at ARVO conference in Seattle

      Bioptigen/NKT Press Release - Bioptigen Inc. has introduced 1 um axial resolution imaging to its line of Envisu TM spectral domain OCT systems. The company has now integrated NKT Photonics SuperK supercontinuum laser with Bioptigen’s new 300 nm spectrometer to achieve a breakthrough in ophthalmic imaging for preclinical research. “The progression to 1 um extreme resolution imaging is an exciting advancement for our Envisu R-Class research product line”, said Dr. Eric Buckland, CEO of Bioptigen. “The importance of this innovation is that it offers researchers true cellular-level in vivo optical histology. This Extreme High Resolution (XHR) capability is unlocked ...

      Read Full Article
      Mentions: NKT Photonics Leica
    9. Bioptigen Introduces First Automated Segmentation Software for Mouse SDOCT

      Bioptigen Introduces First Automated Segmentation Software for Mouse SDOCT

      Bioptigen Press Release - Bioptigen Inc. is launching its latest software solution for preclinical SDOCT image analysis. The new product is called Diver 2.0 and is part of the InVivoVue suite of SDOCT software solutions. InVivoVue software is only available on Bioptigen’s Envisu SDOIS (spectral domain ophthalmic imaging system). Diver 2.0 is only available for R-Class Envisu SDOIS systems. Diver adds features that Envisu users need for further analysis of SDOCT image data including template-based manual marking, automatic thickness analysis across the mouse retina, and PDF and spreadsheet report generation, enabling preclinical researchers to present and further analyze ...

      Read Full Article
      Mentions: Leica
    10. Bioptigen Expands Headquarters Within Research Triangle Park, NC

      Bioptigen Expands Headquarters Within Research Triangle Park, NC

      Bioptigen Inc. is relocating its headquarters to a larger facility, in part to accommodate expanded production of its Envisu ophthalmic imaging system, which the U.S. Food and Drug Administration cleared for use in patients earlier this year. Bioptigen’s relocation to Keystone Technology Park within the Research Triangle Park culminates a year in which the company has successfully gained regulatory clearance to commercially market Envisu in the United States, Canada, Europe and Australia. “This year has been positively monumental for Bioptigen,” said Dr. Eric Buckland, president and CEO. “Now that we’ve been cleared to market Envisu practically worldwide ...

      Read Full Article
    11. Bioptigen Receives FDA Clearance to Market Envisu Imaging Systems in the USA

      Bioptigen Receives FDA Clearance to Market Envisu Imaging Systems in the USA

      Bioptigen Press Release - Devices become first OCT systems cleared for hand-held ophthalmic imaging of children Bioptigen Inc. has received 510(k) clearance from the U.S. Food and Drug Administration to begin marketing its hand-held Envisu Spectral Domain Ophthalmic Imaging System (SDOIS) devices for patient use. The Envisu SDOIS aids in the diagnosis of physiological and pathological conditions of the eye through non-contact optical imaging. In receiving this regulatory clearance, Bioptigen’s Envisu SDOIS become the first optical coherence tomography imaging systems commercially available in the United States for hand-held and pediatric imaging. Envisu’s ergonomic, hand-held scanner enables imaging ...

      Read Full Article
    12. Bioptigen Receives Clearance to Market Envisu SDOIS in Canada

      Bioptigen Receives Clearance to Market Envisu SDOIS in Canada

      Bioptigen Press Release - Canada approves hand-held ophthalmic SDOCT imaging system for patient use   Bioptigen Inc. has received a medical device license from Health Canada to begin marketing its hand-held Envisu SDOIS C2200 and C2300 ophthalmic imaging systems for patient use. Bioptigen’s Envisu C series SDOIS imaging systems use low-power, near-infrared light to generate real-time, high-resolution, depth-resolved images of eye structures, equipping researchers and clinicians to explore new avenues of understanding in eye disease progression, detection and treatment. “Now that Bioptigen has regulatory approval to market our technology in Canada and the European Union, adults and children can begin benefitting ...

      Read Full Article
    13. Bioptigen Envisu SDOCT Used in Rare Elephant Cataract Surgery

      Bioptigen Envisu SDOCT Used in Rare Elephant Cataract Surgery

      Surgery also marked first time SDOCT used to image elephant   Veterinarians used Bioptigen’s Envisu R2300 ophthalmic imaging system in the successful surgical removal of a cataract from C’sar, a 38-year-old African elephant residing at the North Carolina Zoo. The surgery in November represented only the fifth time elephant cataract surgery has been performed anywhere in the world. And it marked the first time that a spectral domain optical coherence tomography (SDOCT) imaging system was used on an elephant. North Carolina Zoo officials say that C’sar’s behavior has improved dramatically since surgery – to the extent that they ...

      Read Full Article
      Mentions: FDA Leica
    14. Bioptigen Named Finalist for Three Prestigious NCTA 21 Awards

      Bioptigen Named Finalist for Three Prestigious NCTA 21 Awards
      Bioptigen Press Release - RESEARCH TRIANGLE PARK, N.C. – The ophthalmic imaging device company, Bioptigen Inc., has been named a finalist in three categories of the 2011 NCTA 21 Awards.   The NCTA 21 Awards are recognized as North Carolina’s largest and most prestigious awards devoted to promoting and celebrating innovation and high-tech excellence throughout the state. The annual showcase honors 21 companies and individuals representing the best and brightest in technology and business, and demonstrating outstanding leadership and innovation.   Bioptigen has created the commercial market’s deepest spectral domain optical coherence tomography (SDOCT) system for pre-clinical applications. NCTA named Bioptigen ...
      Read Full Article
      Mentions: Leica
    15. Bioptigen Awarded $2.7M Phase II SBIR Grant from the National Institutes of Health

      Bioptigen Awarded $2.7M Phase II SBIR Grant from the National Institutes of Health
      Bioptigen Press Release - Company will apply grant to research in pediatric ophthalmology   Bioptigen Press Release - Bioptigen Inc., a medical-device company that has developed innovative ophthalmic imaging technologies for translational research, has been awarded a $2.7 million, 27-month grant from the National Eye Institute of the U.S. National Institutes of Health.   The company will apply the grant to the research of spectral domain optical coherence tomography (SDOCT) systems targeted to the needs of the pediatric population.   “Children have unique eye care needs,” said Dr. Eric L. Buckland, president and CEO of Bioptigen. “It is both exciting and satisfying to ...
      Read Full Article
    1-15 of 15
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics in the News

    1. (14 articles) Leica
    2. (5 articles) FDA
    3. (3 articles) National Institutes of Health
    4. (2 articles) NKT Photonics
    5. (1 articles) National Eye Institute
    6. (1 articles) University of Miami
    7. (1 articles) Carl Zeiss Meditec
  3. Popular Articles

  4. Picture Gallery

    Bioptigen Envisu SDOCT Used in Rare Elephant Cataract Surgery Bioptigen Receives Clearance to Market Envisu SDOIS in Canada Bioptigen Receives FDA Clearance to Market Envisu Imaging Systems in the USA Bioptigen Introduces First Automated Segmentation Software for Mouse SDOCT Bioptigen introduces 1 µm resolution SD-OCT imaging system in collaboration with NKT Photonics supercontinuum white light laser source at ARVO conference in Seattle Bioptigen introduces operating microscope mount for FDA-cleared Envisu ophthalmic imaging system. Bioptigen now shipping Envisu XHR Extreme Resolution OCT Imaging systems Bioptigen Introduces Dynamic 3D Tissue Flattening Software for Envisu SD-OCT Systems  (See Video) Bioptigen Unveils the Envisu IntraSurgical OCT System for Real-time Imaging During Ophthalmic Surgery Leica Microsystems to Acquire OCT Company Bioptigen New insights from non-invasive imaging: from prospection of skin photodamages to training with mobile application Short-sighted woman assumes debilitating headaches mean she needs new glasses but discovers she has multiple sclerosis